CVE-2020-7285
Privilege Escalation vulnerability in McAfee MVISION Endpoint prior to 20.5.0.94 allows a malicious script or program to perform functions that the local executing user has not been granted access to.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.25%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Privilege Escalation vulnerability in McAfee MVISION Endpoint prior to 20.5.0.94 allows a malicious script or program to perform functions that the local executing user has not been granted access to.
- CVSS 3.1
- 7.8 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.25% probability · 17th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-274, CWE-269
- Affected
- mcafee/mvision endpoint
- Source
- trellixpsirt@trellix.com
EPSS 0.3% since 26 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.